Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Celadon Pharmaceuticals (CEL)

Sector:

Alternative Investment Instruments

Index:

FTSE AIM All-Share

160.00p

Change Today:

0.000p
52 Week High: 175.00
52 Week Low: 49.50

Currency: UK Pounds
Shares Issued: 61.67m
Volume: 13,605

Market Cap: £98.67m
RiskGrade: 111

CEL Overview

Celadon is a UK based pharmaceutical company that is focusing on growing indoor hydroponic, high-quality cannabis initially for the chronic pain market. It also intends to further research cannabinoids in the highly regulated UK market.

Competitors:

450

Key Personnel

CEO:	James Short
CFO:	Jonathan Turner
Independent Non-Executive Director:	Liz Shanahan
Independent Non-Executive Director:	Steven (“Steve”) Hajioff
Independent Non-Executive Director:	David Firth
Non-Executive Chairman:	I Alexander Anton
Senior Independent Non-Executive Director:	Robert Barr
Non-Executive Dir:

Contact Details

Address:	32-33 Cowcross Street, London, England, United Kingdom, EC1M 6DF
Phone:	+44 (0)207 4407 500
Website:	https://celadonpharma.co.uk

Listings

Sector:	Alternative Investment Instruments(LSE)
Index:	FTSE AIM All-Share
ISIN:	GB00BDQYGP38

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

CEL Market Data

Currency	UK Pounds
Share Price	160.00p
Change Today	0.000p
% Change	0.00 %
52 Week High	175.00
52 Week Low	49.50
Volume	13,605
Shares Issued	61.67m
Market Cap	£98.67m
RiskGrade	111